Advertisement
News

Fact/Fiction: Is the Moderna vaccine less effective against new variants?

Old news, truthfully retold. This week we look at the Moderna vaccine to see if it really does protect against new Covid-19 variants

Every week in Fact/Fiction, The Big Issue examines spurious claims, questionable studies or debatable stories from the press to determine whether they are fact or fiction. This week we focus on the Moderna vaccine ahead of its arrival in the UK. New studies into how it fares against new Covid-19 variants in the UK and South Africa produced different takes in the press. We investigate.

How it was told

Right now, we all fancy ourselves to be armchair epidemiologists, pinning all our hopes on the vaccines to get us out of this global pandemic.

That’s why any news doubting the efficacy of the injections is a devastating blow and attracts extreme scrutiny. One such story was widely debunked last week when German financial newspaper Handelsblatt claimed the AstraZeneca vaccine had just eight per cent efficacy – though this figure was just a proportion of 56 to 69-year-olds in the study.

Another story examining how effective a vaccine is against new strains of the virus attracted plenty of varying coverage too. The Moderna vaccine, which was approved for use in the UK and is set to be rolled out in the spring, was tested against mutated strains found in the UK and South Africa.

The headlines were mixed. The BBC reported the story as “Moderna vaccine appears to work against variants” while The Sun was equally hopeful, opting for: “JAB BOOST Moderna vaccine DOES protect against ‘deadlier mutant Covid strains’ – as they trial booster to fend off future variants”. Time magazine and the Evening Standard also covered the story in similar fashion.

Elsewhere there were different takes. US broadcaster NPR went for: “Moderna finds Covid-19 vaccine less effective against variant found in South Africa”. The FT’s headline read: “Moderna develops new vaccine to tackle mutant Covid strain”.

Advertisement
Advertisement

So was this a positive story to reassure you that a vaccine will be effective, or is there anything to worry about?

Facts. Checked

This is a reassuring story that shows one of the three major vaccines is still effective against a virus that is continuing to mutate.

In fact, it was the NPR story that raised the ire of epidemiologists online. And subsequently, NPR was moved to change its headline to “Moderna finds Covid-19 vaccine still protects against emerging strains”.

Dr Dylan Morris, a postdoctoral research scholar at the University of California, Los Angeles, described the NPR headline as “not just misleading sensationalism; it’s literally incorrect as stated”.

Dr Morris took issue with the headline based on the use of “effective”, which has a technical meaning in relation
to vaccines as it measures the percentage reduction in a disease in a group of people who received a vaccination in a clinical trial.

In the case of this Moderna study, the efficacy of the vaccine was not assessed in clinical trials with human beings butvia in vitro neutralisation studies in a lab.

The stories come from two studies published by the pharmaceutical firm testing their vaccine against two new strains. While both studies are currently pre-prints and need further research and peer review, “the vaccine is expected to be protective against emerging strains detected to date,” according to Moderna.

It is true that the firm is developing new booster jabs to protect against future strains. As Stéphane Bancel, Moderna chief executive, put it: “We believe it is imperative to be proactive as the virus evolves.”

For the so-called UK strain, neutralising antibody titers – the measurement of the amount or concentration of antibodies found in a person’s blood – remained high and were generally consistent with prior variants.

And for the South African strain, the concentration of titers was approximately six-fold lower when compared to prior variants. This suggests that immunity may wane quicker but the point here is the vaccine still protects against the Covid-19 virus.

Professor Paul Hunter of the University of East Anglia described the results as “not surprising” but said that an accumulation of mutations will impact on the efficacy of vaccines over time. He said: “But this is to be expected and should not pose insurmountable difficulties for control of the epidemic.”

The problem in this case comes from the difficulty in reporting on Covid-19. It’s not easy to cover a story that is constantly evolving and changing and processing technical, complicated science. Here NPR fell foul of that technical language.

But it is important to retain faith in the vaccines as they continue to be rolled out.

Advertisement

Support your local vendor

Want to buy a copy of the magazine? We have over 1,200 Big Issue vendors in the UK. Each vendor buys a copy of the mag for £1.50 and sells it for £3, keeping the difference. Visit our interactive map to find your nearest vendor and support them today!

Recommended for you

Read All
Three quarters of Brits back rent controls to solve England’s housing crisis
Renting

Three quarters of Brits back rent controls to solve England’s housing crisis

Help to Build scheme asks Brits to tackle the housing crisis – but ‘won’t reach those in need’
Housing crisis

Help to Build scheme asks Brits to tackle the housing crisis – but ‘won’t reach those in need’

Glenda Jackson: 'What made me give up acting and go into politics was Margaret Thatcher'
Letter to my younger self

Glenda Jackson: 'What made me give up acting and go into politics was Margaret Thatcher'

The UK is facing a huge skills gap — and Big Issue Group plans to do something about it
Employment crisis

The UK is facing a huge skills gap — and Big Issue Group plans to do something about it

Most Popular

Read All
Exclusive: BT call centre sets up 'food bank' for its own staff
1.

Exclusive: BT call centre sets up 'food bank' for its own staff

Prince William: 'Why I wanted to work with The Big Issue'
2.

Prince William: 'Why I wanted to work with The Big Issue'

Rainn Wilson emailed Star Trek: Strange New Worlds to say Harry Mudd would 'fit right in'
3.

Rainn Wilson emailed Star Trek: Strange New Worlds to say Harry Mudd would 'fit right in'

The UK approach to replacing the Human Rights Act is just as worrying as the replacement itself
4.

The UK approach to replacing the Human Rights Act is just as worrying as the replacement itself

Keep up to date with The Big Issue. The leading voice on life, politics, culture and social activism direct to your inbox.